Skin patches for generic drug delivery.
Company is active
Event Year: 2017
Company is active
Event Year: 2017
Avro Life Science is focused on developing innovative skin patch technologies for the delivery of generic drugs. This approach aims to provide a more convenient and potentially more effective method of drug administration compared to traditional oral medications. By utilizing transdermal patches, Avro Life Science seeks to improve patient compliance and therapeutic outcomes in various healthcare applications. The company is actively working to expand the range of generic drugs that can be effectively delivered through their proprietary patch technology, addressing a significant need in the pharmaceutical industry.
Avro Life Science is focused on developing innovative skin patch technologies for the delivery of generic drugs. This approach aims to provide a more convenient and potentially more effective method of drug administration compared to traditional oral medications. By utilizing transdermal patches, Avro Life Science seeks to improve patient compliance and therapeutic outcomes in various healthcare applications. The company is actively working to expand the range of generic drugs that can be effectively delivered through their proprietary patch technology, addressing a significant need in the pharmaceutical industry.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2018
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2018
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 8
Hiring: No
Team size: 8
Hiring: No
